QT
Q Therapeutics
UT - Salt Lake City
BiotechnologyFocus: CNS Therapies
Q Therapeutics is a life sciences company focused on CNS Therapies.
Neurology
Funding Stage
PUBLIC
Employees
5000+
Open Jobs
0
Pipeline & Clinical Trials
HRQoL surveys
Chronic Obstructive Pulmonary DiseaseClinical Trials (1)
NCT02406534A Prospective, Observational Study of COPD Patients in U.S. Hospitals
N/AL-dopa/Carbidopa
Depressive Disorder, MajorClinical Trials (1)
NCT05909267Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation
N/AOligo Fucoidan
Advanced Hepatocellular CarcinomaClinical Trials (1)
NCT04066660Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)
N/ARestylane and Restylane-L
Nasolabial FoldsClinical Trials (1)
NCT00797459Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds
N/AUse of a PDA to assist shared decision making
Diabetes Mellitus, Type 2Clinical Trials (1)
NCT02110979Validation of a Patient Decision Aid for Type 2 Diabetes
N/ABrown seaweed
Type II DiabetesClinical Trials (1)
NCT04715776Supplementation of Brown Seaweed on Insulin Resistance of NAFLD Patients With Pre- or Type 2-Diabetes
N/ATraditional Pilates group
HypertensionClinical Trials (1)
NCT03791307Effects of Training Based on the Pilates Method on the Blood Pressure of Hypertensive Women
N/APerlane and Perlane-L
Nasolabial FoldsClinical Trials (1)
NCT00823069Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose
N/AAndroferti
Male InfertilityClinical Trials (1)
NCT03466229Impact of Antioxidant Treatment on DNA Fragmentation Index
N/AOligo Fucoidan
NSCLC Stage IVClinical Trials (1)
NCT03130829To Evaluate the QoL Improvement of Oral Oligo Fucoidan in Subjects Receiving Platinum-based Chemotherapy With NSCLC
N/ADeflux
Umbilical HerniaClinical Trials (1)
NCT00706329Minimally Invasive Closure of Umbilical Hernias
N/AExamination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
Huntington's DiseaseClinical Trials (1)
NCT00670709Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
N/AXeltis Vascular Patch, Model COR-VP-001
Heart Defects, CongenitalClinical Trials (1)
NCT02377700Safety and Performance of a Vascular Patch in Pediatric Patients Undergoing Bidirectional Cava-pulmonary Anastomosis
N/AMMV390048 40 mg
MalariaClinical Trials (1)
NCT02783820Safety, Tolerability and Pharmacokinetic Profile of Ascending Oral Doses of MMV390048, Part A
Phase 1MMV390048 20mg
Malaria, FalciparumClinical Trials (1)
NCT02281344MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants
Phase 1KAND145
Ovarian CancerClinical Trials (1)
NCT06063343Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145
Phase 1Administration of the malaria inoculum
MalariaClinical Trials (1)
NCT02431637Experimental Falciparum Transmission to Anopheles
Phase 1480 mg Piperaquine phosphate
MalariaClinical Trials (1)
NCT03542149Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP
Phase 1Placebo
Uterine LeiomyomaClinical Trials (1)
NCT06959966Effects of Oligo-fucoidan on Leiomyoma Patients
Phase 1Budesonide Inhalation Suspension
AsthmaClinical Trials (1)
NCT00627679Safety and Blood Level Study of Unit Dose Budesonide
Phase 1SJ733 Induced Blood Stage Malaria Challenge Study
Plasmodium Falciparum MalariaClinical Trials (1)
NCT02867059SJ733 Induced Blood Stage Malaria Challenge Study
Phase 1DSM265
MalariaClinical Trials (1)
NCT02573857A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection
Phase 1/2Q-Cells
Transverse MyelitisClinical Trials (1)
NCT03887273Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis
Phase 1/2Blood stage parasite
HealthyClinical Trials (1)
NCT01055002A Pilot Study to Test Activity of Antimalarial Drugs Against an Induced Malaria Infection in Healthy Volunteers
Phase 1/2OZ439
MalariaClinical Trials (1)
NCT02431650Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent
Phase 1/2Phase 1/2
Clinical Trials (1)
NCT02478450Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 1/2MMV390048 40mg
MalariaClinical Trials (1)
NCT02783833MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B
Phase 1/2DSM265
MalariaClinical Trials (1)
NCT02389348A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265
Phase 1/2Phase 2
Clinical Trials (1)
NCT00637767High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant
Phase 2Phase 2
Clinical Trials (1)
NCT04597476A Randomized, Double-blind Study to Evaluate the Clinical Effect and Safety of Fucoidan in Patients With Squamous Cell Carcinomas of the Head and Neck
Phase 2Lumentin® 44 Powder for oral foam
HealthyClinical Trials (1)
NCT05781490A Healthy Volunteer Trial Investigating MR-enterography Image Quality of Lumentin® 44
Phase 2Probiotic L008-1
Smoking CessationStudy group - quadrivalent recombinant hemagglutinin influenza vaccine
Influenza, HumanClinical Trials (1)
NCT03460743Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2001
Portfolio: 32 clinical trials